Recognition mechanisms of multiple sclerosis antibody MS with antigens EBNA1 and GlialCAM via molecular dynamics simulations

Abstract

Multiple sclerosis (MS), a severe autoimmune disease of the central nervous system (CNS), is marked by detrimental demyelination and axonal destruction. High-affinity molecular mimicry exists between Epstein-Barr virus nuclear antigen 1 (EBNA1) and glial cell adhesion molecule (GlialCAM) in the CNS, leading to cross-reactivity of the cerebrospinal fluid-derived B-cell monoclonal antibody (mAb) MS39p2w174 with EBNA1 and GlialCAM. We aim to explore two interesting questions using molecular dynamics simulations in explicit solvent: How does molecular mimicry between the two antigens (Ags) contribute to the cross-reactivity of the immune response? What conformational changes occur in the complementarity-determining regions (CDRs) of the mAb upon binding? Remarkably, both Ags are best described by a combination of induced-fit and conformational-selection mechanisms according to local and global structure analysis and the Kolmogorov–Smirnov test, allowing the similar epitopes to be recognized by the same Ab. Conformational characterization suggests the CDR1 loop of the mAb light chain (CDR-L1) experiences significant changes. Binding-energy prediction proves the hydrogen bonds are critical for complex stability, and both CDR-L1 and CDR-H3 (heavy-chain CDR3 loop) are important interaction interfaces. The role of CDR-H3 has been verified by previous studies. Furthermore, the distinct binding characteristics for the two Ags and Ab are demonstrated. EBNA1 shows higher binding affinity, allowing a precise fit and greater complex stability. In contrast, GlialCAM undergoes more significant local conformational changes to achieve structural complementarity, compensating for its lower intrinsic affinity. These differences highlight varied molecular recognition strategies underlying antibody specificity and cross-reactivity. The findings provide a deep understanding of the molecular pathogenesis of MS caused by different Ags with high-affinity molecular mimicry, providing theoretical support for further research.

Graphical abstract: Recognition mechanisms of multiple sclerosis antibody MS with antigens EBNA1 and GlialCAM via molecular dynamics simulations

Supplementary files

Article information

Article type
Paper
Submitted
18 Jul 2025
Accepted
20 Nov 2025
First published
26 Nov 2025

Phys. Chem. Chem. Phys., 2026, Advance Article

Recognition mechanisms of multiple sclerosis antibody MS with antigens EBNA1 and GlialCAM via molecular dynamics simulations

L. Zhang and Q. Yu, Phys. Chem. Chem. Phys., 2026, Advance Article , DOI: 10.1039/D5CP02745D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements